Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102477057A details a full-chemical route for Thio-NAD, offering stable intermediates and cost reduction in biochemical manufacturing for reliable supply.
Novel activated carbon purification method reduces energy costs and simplifies scale-up for isosorbide mononitrate manufacturing.
Patent CN107022587A details a novel enzymatic route for Ezetimibe intermediates using tubular reactors. Discover cost reduction in API manufacturing and high-purity supply solutions.
Novel patent CN111646940B offers high-yield bosutinib intermediate synthesis. Reduces reflux time and enhances purity for reliable pharmaceutical intermediate supply chains.
Novel cefotaxime acid synthesis patent offers high yield and purity. Reduces costs and improves supply chain reliability for pharmaceutical manufacturers globally.
Patent CN112194585A reveals a high-yield reductive amination route for Bromhexine Hydrochloride, eliminating corrosive thionyl chloride and enhancing supply chain stability.
Novel five-step route for Ticagrelor intermediate V reduces cost and improves yield for pharmaceutical supply chains globally ensuring high purity and reliability.
Patent CN104557845A reveals a mild transfer hydrogenation route for Lubiprostone. Achieve high purity and cost reduction in API intermediate manufacturing with scalable methods.
Patent CN102675181B details a solvent-free Levetiracetam synthesis. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel solid-phase synthesis reduces impurities below 0.1 percent ensuring high purity icatibant suitable for commercial scale-up and cost reduction in peptide manufacturing.
Patent CN106674069A reveals high-purity isomerization method. Enables cost reduction in API manufacturing and reliable pharmaceutical intermediate supplier solutions.
Advanced solid-phase synthesis of OXM analogs offers high purity and scalable production. Discover cost-effective solutions for diabetes and obesity therapeutic intermediates.
Patent CN104610357A reveals ionic liquid method for high-purity zoledronic acid sodium. Enables cost reduction and scalable supply chain for global pharmaceutical manufacturers.
Novel synthesis route for benzimidazole derivatives offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing processes globally.
Patent CN102391254B reveals a novel Candesartan synthesis using ethanol protection. Achieve cost reduction in pharmaceutical manufacturing and high-purity yields.
Novel epoxidation route for Voglibose intermediates. Reduces steps, eliminates protection groups, ensures high purity for diabetes drug manufacturing.
Patent CN101735201A reveals a low-cost Piribedil synthesis route. Discover supply chain advantages and high-purity pharmaceutical intermediate manufacturing insights.
Novel DMF carbon source route for oxadiazoles reduces toxic reagents. Reliable supply chain partner offers scalable manufacturing and cost optimization.
Patent CN107793428A details high-purity Artemether production. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced synthesis of 1,5-benzothiazepines via CN101337948B. Delivers superior antifungal activity with scalable, cost-effective manufacturing for global pharmaceutical supply chains.